Drug Trial Radar · NCT07218380
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Last checked: Nov 20, 2026Latest source record: Oct 7, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
450
Planned (sponsor's estimate)
Start
Dec 12, 2025
Primary completion
Oct 2029
Study completion May 2033
Sponsor
- Lead sponsor
- Eli Lilly and CompanyEli Lilly (LLY)
- Sponsor type
- Industry
- First posted
- Oct 20, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to test a new medicine, vepugratinib, in comparison with placebo, to see if it is safe and can help people with a bladder cancer that is advanced or has spread. Vepugratinib or placebo will be administered in combination with enfortumab vedotin and pembrolizumab. Study participation could last up to approximately 6 years.
Conditions
- Carcinoma, Transitional Cell
- Urinary Bladder Neoplasms
- Neoplasm Metastasis
Interventions
VepugratinibDrug
Administered orally
PlaceboOther
Administered orally
EVDrug
Administered by IV infusion
PembrolizumabDrug
Administered by IV infusion
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of participants with treatment-related adverse events related to vepugratinib in combination with EV and pembrolizumabTime frame: From baseline up to 90 months
- Safety Lead-in: Overall Response Rate (ORR)Time frame: From baseline up to 90 months
- Progression-free Survival (PFS)Time frame: Baseline to Study Completion (estimated as 6 years)
Locations
276 sites in 19 countries. Site status is shown where the registry gives one.
The University of Arizona Cancer Center - North Campus
Tucson, Arizona · Recruiting
University of Arkansas for Medical Sciences
Little Rock, Arkansas · Not yet recruiting
Chao Family Comprehensive Cancer Center and Ambulatory Care (CIACC) - Irvine
Irvine, California · Recruiting
TRIO-US (Translational Research in Oncology-US)
Los Angeles, California · Recruiting
UCLA Hematology/Oncology - Santa Monica
Los Angeles, California · Recruiting
University of California, Irvine (UCI) Health - UC Irvine Medical Center
Orange, California · Recruiting
University of California Davis (UC Davis) Comprehensive Cancer Center
Sacramento, California · Recruiting
UCSF Medical Center at Mission Bay
San Francisco, California · Recruiting
Hunt Cancer Institute, an Affiliate of Cedars-Sinai Cancer (TMPN)
Torrance, California · Recruiting
AdventHealth Medical Group - Porter
Denver, Colorado · Not yet recruiting
Colorado West Healthcare System - Grand Valley Oncology
Grand Junction, Colorado · Recruiting
Yale-New Haven Hospital
New Haven, Connecticut · Not yet recruiting
MedStar Washington Hospital Center
Washington D.C., District of Columbia · Not yet recruiting
AdventHealth Orlando
Orlando, Florida · Not yet recruiting
St. Luke's Cancer Institute: Boise
Boise, Idaho · Not yet recruiting
University of Illinois at Chicago
Chicago, Illinois · Recruiting
University of Chicago Medical Center
Chicago, Illinois · Not yet recruiting
Endeavor Health
Evanston, Illinois · Not yet recruiting
Accellacare of Duly
Lisle, Illinois · Not yet recruiting
Parkview Research Center at Parkview Regional Medical Center
Fort Wayne, Indiana · Recruiting
Indiana University Melvin and Bren Simon Cancer Center
Indianapolis, Indiana · Recruiting
Franciscan Health
Indianapolis, Indiana · Recruiting
University of Kentucky Chandler Medical Center
Lexington, Kentucky · Suspended
Mary Bird Perkins Cancer Center
Baton Rouge, Louisiana · Recruiting
Mary Bird Perkins Cancer Center - Metairie
Metairie, Louisiana · Recruiting
Ochsner Clinic Foundation
New Orleans, Louisiana · Not yet recruiting
Johns Hopkins Hospital
Baltimore, Maryland · Recruiting
James M Stockman Cancer Institute
Frederick, Maryland · Not yet recruiting
Massachusetts General Hospital
Boston, Massachusetts · Not yet recruiting
University of Massachusetts Medical School
Worcester, Massachusetts · Not yet recruiting
Karmanos Cancer Institute
Detroit, Michigan · Recruiting
Brigitte Harris Cancer Pavilion
Detroit, Michigan · Not yet recruiting
Oncology Hematology Associates
Springfield, Missouri · Recruiting
Washington University School of Medicine
St Louis, Missouri · Recruiting
Comprehensive Cancer Centers of Nevada
Las Vegas, Nevada · Recruiting
Astera Cancer Care
East Brunswick, New Jersey · Recruiting
Columbia University Irving Medical Center
New York, New York · Recruiting
Memorial Sloan Kettering Cancer Center
New York, New York · Recruiting
Weill Cornell Medical College
New York, New York · Not yet recruiting
Wilmot Cancer Institute
Rochester, New York · Not yet recruiting
Showing 40 of 276 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.